Home > News > Altair Nanotechnologies to Present at the Wall Street Analyst Forum
February 25th, 2004
Altair Nanotechnologies to Present at the Wall Street Analyst Forum
Altair Nanotechnologies Inc. announced today that its President, Dr. Rudi Moerck, will be presenting to members of the financial community at the Wall Street Analyst Forum's Pharmaceutical Conference in New York City on March 1, 2004. Dr. Moerck will provide an overview of Altair Nanotechnologies' technology platform along with an in depth discussion and update of the company's patent-pending pharmaceutical, RenaZorb™. Additionally, Dr. Moerck will discuss the company's new nano-based drug delivery system that may possess properties that reduce the potential for the abuse of narcotics.
Berkeley Lab Researchers Demonstrate First Size-based Chromatography Technique for the Study of Living Cells April 22nd, 2014
PETA science consortium to present hazard testing strategy at nanotoxicology meeting: High tech field ripe for use of sophisticated non-animal testing strategies April 22nd, 2014
Harris & Harris Group Notes the Receipt of Proceeds From the Sale of Molecular Imprints' Semiconductor Business to Canon April 22nd, 2014
National Space Society Congratulates SpaceX on the Success of CRS-3 and the First Flight of the Falcon 9R April 22nd, 2014